LI Jiabing. Expression and clinical significance of Livin in benign prostate hyperplasia and prostate cancer. [J]. Journal of Chongqing Medical University (7):689-691(2007)
LI Jiabing. Expression and clinical significance of Livin in benign prostate hyperplasia and prostate cancer. [J]. Journal of Chongqing Medical University (7):689-691(2007) DOI: 10.13406/j.cnki.cyxb.2007.07.025.
Expression and clinical significance of Livin in benign prostate hyperplasia and prostate cancer
Objective:To examine and analyze the expression of two isoforms of Livin(Livinαand Livinβ)
a novel inhibitor of apoptosis protein(IAP)family member in benign prostate hyperplasia(BPH)and prostate cancer(PC)
and to explore relationship between Livin expression and prostate cancer.Methods:Livin mRNA in BPH
PC and normal protate tissue(NP)were detected by reverse transcription polymerase chain reaction(RT-PCR).Results:LivinαmRNA was expressed in 17 of 26 PC cases(65.38%) and in 12 of 20 BPH cases(60.00%)
No Livinαexpression was detected in NP
Livinβwas not detected in BPH
PC and NP.The Livinαpositive expression ratios had significant differences(P<0.05)between NP and BPH or PC
No significant differ- ence of Livinαpositive expression ratio was found between BPH and PC(P>0.05).There was no relationship(P>0.05)between the Livinαexpression and histologic grade or clinical stage of PC.Conclusion:Livinαis highly expressed in PC and BPH
which may play an important role in generation and progression of PC and BPH